Compare PD & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PD | EMBC |
|---|---|---|
| Founded | 2009 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 636.9M | 521.7M |
| IPO Year | 2019 | 2021 |
| Metric | PD | EMBC |
|---|---|---|
| Price | $6.22 | $8.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $12.63 | ★ $18.50 |
| AVG Volume (30 Days) | ★ 3.0M | 805.7K |
| Earning Date | 03-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 6.79% |
| EPS Growth | ★ 416.95 | 20.90 |
| EPS | ★ 1.87 | 0.74 |
| Revenue | ★ $492,546,000.00 | N/A |
| Revenue This Year | $3.58 | $1.17 |
| Revenue Next Year | $1.65 | N/A |
| P/E Ratio | ★ $3.29 | $11.95 |
| Revenue Growth | ★ 5.36 | N/A |
| 52 Week Low | $5.92 | $8.47 |
| 52 Week High | $18.51 | $15.55 |
| Indicator | PD | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 32.27 | 39.76 |
| Support Level | $6.17 | $8.72 |
| Resistance Level | $16.47 | $9.47 |
| Average True Range (ATR) | 0.42 | 0.35 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 17.37 | 39.20 |
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.